A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis

NCT07229742 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Lupus Nephritis

Interventions

DRUG: SHR-2173 Injection
DRUG: SHR-2173 Injection Blank Preparation

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd